Induction of obliterative airway disease in murine tracheal allografts by CD8+ CTLs recognizing a single minor histocompatibility antigen

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 1871-1878

  Higuchi, Toru ^a   Maruyama, Takahiro ^a   Jaramillo, Andrés ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MINOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE;

ALLELE; ALLOGRAFT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; BRONCHIOLITIS OBLITERANS; CELL KINETICS; CHRONIC GRAFT REJECTION; CONGENIC STRAIN; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; HETEROTOPIC TRANSPLANTATION; HISTOPATHOLOGY; HLA MATCHING; IMMUNIZATION; LUNG GRAFT REJECTION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; RECIPIENT; RESPIRATORY TRACT DISEASE; TRACHEA SURGERY;

EID: 13544259006     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.1871     Document Type: Article

References (51)

1. Sherman, A. L., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385.
2. Mauck, K. A., and J. D. Hosenpud. 1996. The bronchial epithelium: a potential allogenic target for chronic rejection after lung transplantation. J. Heart Lung Transplant. 15:709.
3. Kelly, K., and M. I. Hertz. 1997. Obliterative bronchiolitis. Clin. Chest Med. 18:319.
4. Tullius, S. G., and N. L. Tilney. 1995. Both alloantigen-dependent and independent factors influence chronic allograft rejection. Transplantation 59:313.
5. SivaSai, K. S. R., M. A. Smith, N. Poindexter, R. S. Sundaresan, E. Trulock, J. P. Lynch, J. D. Cooper, G. A. Patterson, and T. Mohanakumar. 1999. Indirect recognition of donor HLA class I peptides in lung transplantation recipients with bronchiolitis obliterans syndrome. Transplantation 67:1094.
6. Reznik, S. I., A. Jaramillo, K. S. R. SivaSai, K. L. Womer, M. H. Sayegh, E. P. Trulock, G. A. Patterson, and T. Mohanakumar. 2001. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am. J. Transplant. 1:228.
7. Lu, K. C., A. Jaramillo, E. N. Mendeloff, C. B. Huddleston, S. C. Sweet, G. A. Patterson, and T. Mohanakumar. 2003. Concomitant allorecognition of mismatched donor HLA class I- and II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 22:35.
8. de Haan, A., I. van der Gun, and B. G. Hepkema. 2000. Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndrome. Transplantation 69:1434.
9. Hertz, M. I., J. Jessurun, M. B. King, and J. J. Murray. 1993. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am. J. Pathol. 142:1945.
10. Kelly, K. E., M. I. Hertz, and D. L. Mueller. 1998. T cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas. Transplantation 66:764.
11. Neuringer, I. P., R. B. Mannon, T. M. Coffman, M. Parsons, K. Burns, J. R. Yankaskas, and R. M. Aris. 1998. Immune cells in a mouse airway model of obliterative bronchiolitis. Am. J. Respir. Cell Mol. Biol. 19:379.
12. + T cells in murine heterotopic tracheal allografts. Transplantation 74:646.
13. + T cells that cause obliterative airways disease. J. Immunol. 172:3469.
14. Liu, Z., P. E. Harris, A. I. Coloval, E. F. Reed, A. Maffei, and N. Suciu-Foca. 1996. Indirect recognition of donor MHC class II antigens in human transplantation. Clin. Immunol. Immunopathol. 78:228.
15. Molajoni, E. R., P. Cinti, A. Orlandini, J. Molajoni, S. Tugulea, E. Ho, Z. Liu, N. Suciu-Foca, and R. Cortesini. 1997. Mechanism of liver allograft rejection: the indirect recognition pathway. Hum. Immunol. 53:57.
16. Vella, J. P., M. Spadafora-Ferreira, B. Murphy, S. I. Alexander, W. Harmon, C. B. Carpenter, and M. H. Sayegh. 1997. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 64:795.
17. Clubotariu, R., Z. Liu, A. I. Colovai, E. Ho, S. Itescu, S. Ravalli, M. A. Hardy, R. Cortesini, E. A. Rose, and N. Suciu-Foca. 1998. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J. Clin. Invest. 101:398.
18. Pettigrew, G. J., E. Lovegrove, J. A. Bradley, J. Maclean, and E. M. Bolton. 1998. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class 1 disparate heart grafts. J. Immunol. 161:1292.
19. Ting, A., and E. Simpson. 1989. Major and minor histocompatibility antigens. In Organ Transplantation: Current Clinical and Immunological Concepts. L. Brent and R. A. Sells, eds. Bailliere Tindall, London, p. 1.
20. Goulmy, E. 1996. Human minor histocompatibility antigens. Curr. Opin. Immunol. 8:75.
21. Simpson, E., and D. Roopenian. 1997. Minor histocompatibility antigens. Curr. Opin. Immunol. 9:655.
22. Simpson, E. 1991. Minor histocompatibility antigens. Immunol. Lett. 29:10.
23. Mendoza, L. M., P. Paz, A. Zuberi, G. Christianson, D. Roopenian, and N. Shastri. 1997. Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity 7:461.
24. Wang, W., L. R. Meadows, J. M. M. denHaan, N. E. Sherman, Y. Chen, E. Blokland, J. Shabanowitz, A. I. Agulnik, R. C. Hendrickson, C. E. Bishop, et al. 1995. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269:1588.
25. Meadows, L., W. Wang, J. M. denHaan, E. Blokalnd, C. Reinhardus, J. W. Drijfhout, J. Shabanowitz, R. Pierce, A. I. Agulnik, C. E. Bishop, et al. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6:273.
26. Malarkannan, S., T. Horng, P. Eden, F. Gonzalez, P. Shin, N. Brouwenstijn, H. Klinge, G. Christianson, D. Roopenian, and N. Shastri. 2000. Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens. Immunity 13:333.
27. Scott, D., C. Addey, P. Ellis, E. James, M. J. Mitchell, N. Saut, S. Jurcevic, and E. Simpson. 2000. Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity 12:711.
28. Choi, E. Y., Y. Yoshimura, G. J. Christianson, T. J. Sproule, S. Malarkannan, N. Shastri, S. Joyce, and D. C. Roopenian. 2001. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others. J. Immunol. 166:4370.
29. Graff, R. J., D. Brown, and G. D. Snell. 1973. The new alleles of the H-3 locus. Transplant. Proc. 5:299.
30. Graff, R. J., D. H. Brown, and G. D. Snell. 1978. The alleles of the H-13 locus. Immunogenetics 7:413.
31. Counce, S., P. Smith, R. Barter, and G. D. Snell. 1956. Strong and weal histocompatibility fine differences in mice and their role in the rejection of homografts of tumors and skin. Ann. Surg. 144:198.
32. Chai, J.-G., E. James, H. Dewchand, E. Simpson, and D. Scott. 2004. Transplantation tolerance induced by intranasal administration of HY peptides. Blood 103:3951.
33. Goulmy, E., R. Schipper, J. Pool, E. Blokland, F. Falkenburg, J. Vossen, A. Gratwohl, G. Vogelsang, H. van Houwelingen, and J. J. van Rood. 1996. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334:281.
34. Vogt, M. H., E. Goulmy, F. M. Kloosterboer, E. Blokland, R. A. dePaus, R. Willemze, and J. H. Falkenburg. 2000. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 96:3126.
35. Voogt, P. J., W. E. Fibbe, W. A. F. Marijt, E. Goulmy, W. F. Veenhof, M. Hamilton, A. Brand, F. E. Zwann, R. Willemze, and J. J. van Rood. 1990. Rejection of bone marrow graft by recipient-derived cytotoxic T lymphocytes directed against minor histocompatibility antigens. Lancet 335:131.
36. + T cells, and HA-1 microchimerism, in allograft tolerance. J. Exp. Med. 199:1017.
37. Roopenian, D. C., A. P. Davis, G. J. Christianson, and L. E. Mobraaten. 1993. The functional basis of minor histocompatibility loci. J. Immunol. 151:4595.
38. Bercovici, N., J. Delon, C. Cambouris, N. Escriou, P. Debre, and R. S. Liblau. 1999. Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice. Eur. J. Immunol. 29:345.
39. + cells in the induction of peripheral tolerance. J. Immunol. 152:2222.
40. + T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:188.
41. Smith, M. A., A. Jaramillo, K. S. R. SivaSai, B. Naziruddin, Z. Kaleem, G. A. Patterson, and T. Mohanakumar. 2002. Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts. Transplantation 73:186.
42. Koulack, J., V. C. McAlister, M. A. MacAulay, H. Bitter-Suermann, A. S. MacDonald, and T. D. Lee. 1996. Importance of minor histocompatibility antigens in the development of allograft arteriosclerosis. Clin. Immunol. Immunopathol. 80:273.
43. Karnovsky, M. J., M. E. Russell, W. Hancock, M. H. Sayegh, and D. H. Adams. 1994. Chronic rejection in experimental cardiac transplantation in a rat model. Clin. Transplant. 8:308.
44. + cytotoxic T cells. Transplantation 76:84.
45. Hirsch, G. M., J. Kearsey, T. Burt, M. J. Karnovsky, and T. Lee. 1998. Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis. Eur. J. Cardiothorac. Surg. 14:89.
46. + T cells in the pathogenesis of chronic rejection. Transplant. Proc. 33:319.
47. + T cells in living kidney transplant patients with long-term allograft acceptance. Hum. Immunol. 62:1335.
48. - T cells in heart transplant recipients. Hum. Immunol. 64:31.
49. + T cells mediate acquired central transplantation tolerance. J. Immunol. 170:279.
50. Sundstedt, A., E. J. O'Neill, K. S. Nicolson, and D. C. Wraith. 2003. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170:1240.
51. + regulatory T cell mediated immunosuppression. Cytokine Growth Factor Rev. 14:85.